Corticosteroid prevents COVID-19 progression within its therapeutic window: a multicentre, proof-of-concept, observational study

Critically ill patients with coronavirus diseases 2019 (COVID-19) are of grave concern. Those patients usually underwent a stage of excessive inflammation before developing acute respiratory distress syndrome. In this study, we test the hypothesis that short-term, low-to-moderate-dose corticosteroid...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yang, Zhou, Xian, Li, Tao, Chan, Shiji, Yu, Yiqi, Ai, Jing-Wen, Zhang, Haocheng, Sun, Feng, Zhang, Qiran, Zhu, Lei, Shao, Lingyun, Xu, Bin, Zhang, Wenhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473313/
https://www.ncbi.nlm.nih.gov/pubmed/32795143
http://dx.doi.org/10.1080/22221751.2020.1807885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473313/
https://www.ncbi.nlm.nih.gov/pubmed/32795143
http://dx.doi.org/10.1080/22221751.2020.1807885

Ejemplares similares